KUALA LUMPUR (Bernama) -- My E.G. Services Bhd has signed a letter of intent (LOI) to purchase 10 million doses of Anhui Zhifei Biopharmaceutical Co Ltd’s COVID-19 vaccine, ensuring that the corresponding quantity of its recombinant protein subunit vaccine is reserved for delivery as early as August.
In a filing with Bursa Malaysia, MYEG said it holds three-year rights to exclusively distribute the vaccine in Malaysia while through a separate partnership, the group has two-year exclusive distribution rights to the vaccine in the Philippines and is presently in discussions to distribute in other countries.
"Last week, MYEG announced plans for the roll-out of a vaccination programme in the Philippines that will cover the provision of the vaccines to the public health segment as well as private sales,” it said.
The LOI is to ensure that the corresponding quantity of Zhifei’s recombinant protein subunit vaccine is reserved for delivery as early as August when vaccination through the private market is enabled.
"This paves the way for the vaccine to be imported and made available to Malaysians as soon as the private market commences and subject to the conditional authorisation of the vaccine by the National Pharmaceutical Regulatory Agency (NPRA),” it said.
The cost of the vaccine will be determined later subject to the conditional authorisation by NPRA.
MYEG said it is confident that when the Zhifei vaccine becomes available locally, it can play an important role in accelerating the country’s drive towards achieving herd immunity against the COVID-19 virus.
Jointly developed by Zhifei and the Institute of Microbiology of the Chinese Academy of Sciences, the vaccine has fast emerged as among the preferred vaccines in China since gaining emergency use authorisation there in early March in view of its distinct inherent advantages as a recombinant protein subunit vaccine. More than 60 million doses have already been administered in more than a dozen provincial-level regions, including Beijing. The vaccine is also being used in Uzbekistan.
Recombinant protein technology is proven, having been used for the development of vaccines such as hepatitis B and shingles.
In addition, recombinant protein vaccines can be more easily produced at a large-scale since production does not need to be carried out in high-grade biosafety laboratories, and they are also more cost-effective and easier to store and transport.
Since the outbreak of the COVID-19 virus, MYEG has leveraged its strengths and expertise as a leading digital services provider in the region to introduce a number of significant initiatives as part of a holistic solution aimed at helping in the fight against the pandemic.
Besides vaccines, these offerings include screening services, quarantine management and digital health travel pass systems.
I stuck in IRIS since February and cut loss in May at 275. Immediately cover and get more profit by trade in Sasbadi & MPAY within 1 month.. dont waste your time here..
what on earth 117 Million in short term funds and more private placement? is acquisition on the cards? common management who is the new CEO/President
Date of change 01 Mar 2021 Name DATO' POH YANG HONG Age 48 Gender Male Nationality Malaysia Designation President Directorate Executive Type of change Resignation
Jangan buang masa.. Itu largest dan 2nd largest shareholder takde intention nak naikkan harga IRIS... Siapa cuba naikkan, diorang jual kasi jatuh balik...
Lagi ramai org CutLoss lagi untung diorang ni...
Shorting pun ade yang main ... tiap2 hari ade 4,393,100 shares kena Short..
Takat u bilis sekor dua... beku la dalam ni.. mau kena ramai... tu pun belum tentu boleh lawan Shorting dan 2 org tu...
-------------------------------------------------
Terry Ong Still cheap for a counter with secured billion project Directors are collecting cheap. Upside outweighs calculated risk 25/06/2021 6:21 PM Terry Ong Robin Tan is still the major shareholder In fact 2nd largest 25/06/2021 7:22 PM
Introducing MY's First IPO Fund for Sophisticated Investors!
MQ Chat
New Update. Discover investment communities that resonate with your ideas
MQ Trader
M & A Value Partners IPO Equity Fund has been launched - Targeted 13% Return p.a
Latest Videos
0:17
New IPO: The onshore and offshore support services provider for the O&G industry, Steel Hawk Bhd aims to list on the Ace Market!
MQ Trader 3089 views | 2 d ago
0:17
New IPO: The largest mini-market player and a leading groceries retailer in Malaysia, 99 Speed Mart Retail Holdings Bhd aims to list on the Main Market!
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....
Gordon Weng M.T
190 posts
Posted by Gordon Weng M.T > 2021-06-23 07:49 | Report Abuse
This stock cannot make it...